Track sentiment, discussions and live quotes, post ideas and see what real traders are doing

A Wells Fargo analyst downgrade to Underweight is driving the attention and sharp selling in Netflix, with traders also debating the conflicting bullish Evercore view. The community is split between bearish concerns about slowing growth, valuation and persistent weakness, and buyers citing advertising growth, buybacks, live sports and strong earnings as reasons to accumulate the dip.

Ultragenyxs full FDA approval of Fayuvi, the first treatment for Sanfilippo syndrome type A, is driving attention, with traders highlighting the new commercial opportunity and accompanying Priority Review Voucher. The community is broadly bullish but debates whether the stocks muted reaction reflects limited patient numbers, commercialization and cash-burn concerns, or potential short-covering and further institutional interest.

A sharp NEAR rally is driving momentum and short-squeeze speculation, with bullish traders highlighting the tokens AI, chain-abstraction and NEAR Intents utility. Skeptics argue the move is largely liquidity- or whale-driven and warn that it may be a pump without a clear catalyst.

A reported but unverified plan for AMD to raise prices on some AI accelerators and graphics products, attributed to higher TSMC wafer costs, is adding to a broader AI-chip rebound. Traders are largely bullish on momentum, short-squeeze and call activity, while some warn the move is overextended and vulnerable to profit-taking.

Anticipation of HLP003s Phase 3 readout is driving attention, reinforced by completed enrollment, conference commentary from the new CEO, and reported insider buying. Traders are bullish on the drugs earlier efficacy signals and potential psychedelic-sector re-rating, while skeptics cite clinical-stage uncertainty and future dilution risk.

SpaceXs plans to expand Starlink into a full mobile network are driving attention, with traders debating whether the service could take meaningful wireless customers from AT&T or remains a long-term, capital-intensive threat. Bullish participants point to AT&Ts strong wireless and fiber additions, cash flow, buybacks and satellite partnerships as offsets, while others remain concerned about intensified telecom competition.

Fresh, unconfirmed buyout speculation is driving attention, with traders debating whether rumored interest from large pharmaceutical companies reflects a genuine bidding process or an options-focused pump. The discussion is supported by confidence in BRIUMVIs commercial growth and the potential impact of upcoming subcutaneous data, while some traders favor continued standalone growth if no deal emerges.

Amazons launch of Supply Chain Services is driving attention, with traders concerned that its freight, fulfillment and delivery network could intensify competition and pressure UPSs volumes and margins. The community is split between viewing the selloff as an overreaction and buying opportunity versus warning that Amazons scale, elevated labor costs and dividend burden threaten UPSs long-term turnaround.

Rallying Hyperliquid (HYPE) prices and continued growth of PURRs HYPE treasury are driving attention, with traders viewing the company as a leveraged proxy for the ecosystem and anticipating a potential short squeeze. Bullish commentary is tempered by concerns about dilution, token unlocks, overbought conditions, and profit-taking.

ServiceTitan is drawing attention after a quarterly report that beat expectations but included softer near-term revenue guidance, slowing growth concerns, an AI product transition, and a chief revenue officer change. Traders are split between viewing the selloff as an excessive reaction and seeing it as a deeper valuation and business reset, with heavy volume and short-selling intensifying the debate.